30 257

Cited 0 times in

Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease.

Authors
Yi, G; Youn, YN; Yoo, KJ; Hong, YS
Citation
The Annals of thoracic surgery, 86(5):1438-1443, 2008
Journal Title
The Annals of thoracic surgery
ISSN
0003-49751552-6259
Abstract
BACKGROUND: Drug-eluting stents (DESs) have challenged coronary bypass grafting as the gold standard for 3-vessel coronary artery disease. This study compared the clinical results between percutaneous intervention with DESs vs off-pump coronary bypass surgery (OPCAB).



METHODS: The study included 388 matched patients with 3-vessel coronary artery diseases who were treated either with DESs or OPCAB. We compared 30-day, 12-month, and cumulative major adverse cardiac and cerebrovascular events (MACCE) during the follow-up.



RESULTS: The overall follow-up was 98.5%. Follow-up duration was 621.1 +/- 259.9 days (range, 13 to 1117 days). The rates of MAACE in the DES and OPCAB group were, respectively, 1.5% at 30 days (p = 0.315) and 9.8% and 3.6% at 12 months (p = 0.015). During follow-up, five deaths occurred in the DES group and one in OPCAB group (p = 0.1). Three-year survival rate was 95.1% +/- 2.9% in DES group and 99.5% +/- 0.5% in OPCAB group (p = 0.075). Survival free from MACCE at 3 years was 73.3% +/- 5.3% in DES group and 91.3% +/- 2.9% in OPCAB group (p < 0.001). The major event for the differences between the groups was target vessel revascularization (p < 0.001): 21 DES patients (10.8%) vs 6 OPCAB patients (3.1%).



CONCLUSIONS: OPCAB showed better clinical outcome in 12-month and cumulative MACCE rate in 3-vessel coronary artery diseases. The major factor for the difference was target vessel revascularization. Longer follow-up is needed to clarify the differences between the two groups.
MeSH terms
Angioplasty, Balloon, Coronary*Cardiopulmonary Bypass/adverse effectsCerebrovascular Disorders/etiologyCerebrovascular Disorders/prevention & controlCoronary Artery Bypass*Coronary Disease/therapy*Coronary Restenosis/prevention & controlDrug-Eluting Stents*FemaleFollow-Up StudiesHumansKaplan-Meier EstimateMaleMiddle AgedMyocardial Revascularization/methodsRecurrenceSurvival AnalysisTreatment OutcomeVascular Patency
DOI
10.1016/j.athoracsur.2008.07.040
PMID
19049727
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Thoracic & Cardiovascular Surgery
AJOU Authors
홍, 유선
Full Text Link
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse